TY - JOUR AU - Nassiri, Farshad AU - Wang, Justin Z AU - Singh, Olivia AU - Karimi, Shirin AU - Dalcourt, Tatyana AU - Ijad, Nazanin AU - Pirouzmand, Neda AU - Ng, Ho-Keung AU - Saladino, Andrea AU - Pollo, Bianca AU - Dimeco, Francesco AU - Yip, Stephen AU - Gao, Andrew AU - Aldape, Kenneth D AU - Zadeh, Gelareh AU - Aldape, Kenneth AU - Au, Karolyn AU - Barnholtz-Sloan, Jill AU - Behling, Felix AU - Bi, Wenya AU - Brastianos, Priscilla AU - Butowski, Nicholas AU - Brodie, Chaya AU - Cohen-Gadol, Aaron AU - Couce, Marta AU - Dimeco, Francesco AU - Drummond, Kate AU - Dunn, Ian AU - Cohen-Gadol, Aaron AU - Galanis, Eva AU - Galldiks, Norbert AU - Giannini, Caterina AU - Goldbrunner, Roland AU - Hanemann, Oliver AU - Herold-Mende, Christel AU - Horbinski, Craig AU - Huang, Raymond AU - Javadpour, Mohsen AU - Jenkinson, Michael AU - Jungk, Christine AU - Kaufmann, Timothy AU - Krischek, Boris AU - Kurz, Sylvia AU - Lachance, Daniel AU - Lafougere, Christian AU - Lamszus, Katrin AU - Lee, Ian AU - Malta, Tathiana AU - Makarenko, Serge AU - Mawrin, Christian AU - McDermott, Michael AU - Millward, Christopher AU - Moliterno-Gunel, Jennifer AU - Morokoff, Andrew AU - Nassiri, Farshad AU - Ng, H. K. AU - Noushmehr, Houtan AU - Perry, Arie AU - Poisson, Laila AU - Pollo, Bianco AU - Ragunathan, Aditya AU - Raleigh, David AU - Renovanz, Mirjam AU - Ricklefs, Franz AU - Sahm, Felix AU - Saladino, Andrea AU - Santacroce, Antonio AU - Santarius, Thomas AU - Schichor, Christian AU - Schimdt, Nils AU - Schittenhelm, Jens AU - Selman, Warren AU - Shih, Helen AU - Snyder, Jim AU - Snuderl, Matja AU - Sloan, Andrew AU - Suppiah, Suganth AU - Sulman, Erik AU - Tabatabai, Ghazaleh AU - Tatagiba, Marcos AU - Timmer, Marcos AU - Tonn, Joerg-Christian AU - Von Deimling, Andreas AU - Vogelbaum, Michael AU - Walbert, Tobias AU - Wang, Justin AU - Wen, Patrick AU - Westphal, Manfred AU - Yip, Stephen AU - Zadeh, Gelareh TI - Loss of H3K27me3 in meningiomas JO - Neuro-Oncology VL - 23 IS - 8 SN - 1523-5866 CY - Oxford PB - Oxford Univ. Press M1 - FZJ-2021-03168 SP - 1282 - 1291 PY - 2021 AB - BackgroundThere is a critical need for objective and reliable biomarkers of outcome in meningiomas beyond WHO classification. Loss of H3K27me3 has been reported as a prognostically unfavorable alteration in meningiomas. We sought to independently evaluate the reproducibility and prognostic value of H3K27me3 loss by immunohistochemistry (IHC) in a multicenter study.MethodsIHC staining for H3K27me3 and analyses of whole slides from 181 meningiomas across three centers was performed. Staining was analyzed by dichotomization into loss and retained immunoreactivity, and using a 3-tiered scoring system in 151 cases with clear staining. Associations of grouping with outcome were performed using Kaplan-Meier survival estimates.ResultsA total of 21 of 151 tumors (13.9%) demonstrated complete loss of H3K27me3 staining in tumor with retained endothelial staining. Overall, loss of H3K27me3 portended a worse outcome with shorter times to recurrence in our cohort, particularly for WHO grade 2 tumors which were enriched in our study. There were no differences in recurrence-free survival (RFS) for WHO grade 3 patients with retained vs loss of H3K27me3. Scoring by a 3-tiered system did not add further insights into the prognostic value of this H3K27me3 loss. Overall, loss of H3K27me3 was not independently associated with RFS after controlling for WHO grade, extent of resection, sex, age, and recurrence status of tumor on multivariable Cox regression analysis.ConclusionsLoss of H3K27me3 identifies a subset of WHO grade 2 and possibly WHO grade 1 meningiomas with increased recurrence risk. Pooled analyses of a larger cohort of samples with standardized reporting of clinical definitions and staining patterns are warranted. LB - PUB:(DE-HGF)16 C6 - pmid:33970242 UR - <Go to ISI:>//WOS:000685248000012 DO - DOI:10.1093/neuonc/noab036 UR - https://juser.fz-juelich.de/record/894308 ER -